Related Experiment Videos
Pyridoxine: a potential local antidote for Mitomycin-C extravasation
1Department of Internal Medicine, Loma Linda University Medical Center, California 92350.
Journal of Surgical Oncology
|April 1, 1988
Summary
Pyridoxine injections may prevent tissue damage and reduce pain from Mitomycin-C extravasation. This treatment offers a potential solution for managing chemotherapy side effects.
Area of Science:
- Oncology
- Pharmacology
- Dermatology
Background:
- Mitomycin-C is a chemotherapy agent.
- Extravasation of Mitomycin-C can cause severe tissue damage (necrosis) and chronic ulceration.
- Pain is a significant symptom of Mitomycin-C extravasation.
Observation:
- Two cases of Mitomycin-C extravasation were treated.
- Pyridoxine (vitamin B6) was injected directly into the extravasation site.
- The treatment aimed to mitigate the adverse effects of Mitomycin-C extravasation.
Findings:
- Pyridoxine injection appeared to slow or prevent necrosis at the extravasation site.
- Patients reported decreased pain associated with the chronic ulceration.
- The findings suggest a potential therapeutic role for pyridoxine.
Implications:
- Pyridoxine may be a viable co-therapy for Mitomycin-C extravasation.
- This approach could improve patient outcomes and quality of life.
- Further clinical studies are warranted to confirm efficacy and optimal dosing.